Log in
Topical acidifying agent

Lactic acid

Lactic acid is an alpha-hydroxy acid (AHA) used topically for vaginal acidification and dermatologic keratolysis. Its primary therapeutic role is restoring normal vaginal pH in bacterial vaginosis and vaginitis, and promoting skin exfoliation in dermatology. The most testable fact is that lactic acid lowers vaginal pH to inhibit pathogenic bacterial overgrowth while supporting lactobacilli colonization.

Drug classAlpha-hydroxy acid, topical acidifying agent
MechanismLowers pH, promotes desquamation, supports normal vaginal flora
Main usesBacterial vaginosis, vaginal pH normalization, chemical exfoliation
Key adverse effectLocal irritation, burning sensation at application site
7 min readFor medical studentsUpdated 2026-10-14

Mechanism of action

Lactic acid functions through multiple complementary mechanisms depending on the site of application.

Vaginal use: Lactic acid is a naturally occurring organic acid produced by vaginal lactobacilli (primarily Lactobacillus crispatus and L. jensenii). When applied topically to the vagina, it lowers pH to the normal acidic range (3.8-4.5). This acidic environment inhibits the growth of pathogenic bacteria such as Gardnerella vaginalis, anaerobes, and other organisms associated with bacterial vaginosis, while creating favorable conditions for recolonization by hydrogen peroxide-producing lactobacilli. The acidic pH also disrupts bacterial biofilms and interferes with bacterial adherence to vaginal epithelium.

Dermatologic use: As an alpha-hydroxy acid, lactic acid weakens intercellular cohesion in the stratum corneum by disrupting ionic bonds between corneocytes. This promotes desquamation and epidermal turnover. At higher concentrations, it causes epidermolysis. Lactic acid also functions as a humectant, attracting and retaining moisture in the stratum corneum. It stimulates ceramide synthesis and may enhance dermal collagen production through fibroblast stimulation.

Lactic acid exists in two stereoisomers: L-lactic acid (the naturally occurring form in mammalian metabolism) and D-lactic acid. Pharmaceutical preparations typically contain L-lactic acid or racemic mixtures.

High-yield for exams
  • Lactic acid lowers vaginal pH to 3.8-4.5, inhibiting bacterial vaginosis pathogens while supporting lactobacilli growth
  • Normal vaginal lactobacilli produce lactic acid as their primary mechanism of colonization resistance against pathogens
  • As an alpha-hydroxy acid, lactic acid disrupts corneocyte cohesion and promotes epidermal desquamation
  • Bacterial vaginosis is characterized by pH >4.5; lactic acid gel reduces recurrence by ~50% when used as maintenance therapy
  • Lactic acid increases photosensitivity; sunscreen is essential during dermatologic treatment
  • Higher concentrations and lower pH formulations penetrate deeper and cause more irritation
  • Topical lactic acid has minimal systemic absorption and no significant systemic drug interactions
  • Concurrent use with retinoids or other exfoliants increases irritation risk; alternating schedules are recommended

Indications

Gynecologic indications:

  • Bacterial vaginosis (adjunctive or maintenance therapy)
  • Vaginal pH normalization in atrophic vaginitis
  • Restoration of vaginal flora after antibiotic therapy
  • Desquamative inflammatory vaginitis
  • Prevention of recurrent bacterial vaginosis

Dermatologic indications:

  • Ichthyosis vulgaris and other disorders of keratinization
  • Xerosis (dry skin)
  • Photoaged skin and fine wrinkles
  • Melasma and post-inflammatory hyperpigmentation
  • Acne vulgaris (mild to moderate)
  • Keratosis pilaris
  • Warts (as a keratolytic agent)

In gynecologic practice, lactic acid is often used as maintenance therapy following antibiotic treatment for bacterial vaginosis to reduce recurrence rates. In dermatology, it is incorporated into moisturizers, chemical peels, and anti-aging formulations at concentrations that vary based on product type and intended use, with professional formulations using higher concentrations than over-the-counter products.

Pharmacokinetics

Absorption: Lactic acid applied topically to intact skin undergoes minimal systemic absorption. In vaginal preparations, some absorption occurs across vaginal mucosa, but the amount is not clinically significant. When applied to denuded or extensively damaged skin, systemic absorption may increase.

Distribution: Any systemically absorbed lactic acid enters the general circulation and is rapidly distributed. Endogenous lactic acid is ubiquitous in human tissues as an intermediate of glucose metabolism.

Metabolism: Absorbed lactic acid is metabolized primarily in the liver via conversion to pyruvate by lactate dehydrogenase, then enters gluconeogenesis or the citric acid cycle. The kidneys also metabolize lactate. This metabolic pathway is identical to that of endogenously produced lactic acid from anaerobic glycolysis.

Elimination: Lactic acid is not renally excreted in significant amounts because it is almost entirely metabolized. The half-life of exogenous lactic acid in plasma is very short (minutes), as it is rapidly cleared by hepatic and renal metabolism.

Special populations: No dose adjustment is required in renal or hepatic impairment for topical use. The metabolic capacity for lactic acid is substantial because of its role as a normal metabolic intermediate.

Adverse effects

Lactic acid is generally well tolerated when used as directed. Adverse effects are predominantly local.

Common (vaginal preparations):

  • Vulvovaginal burning or stinging (usually transient)
  • Vaginal discharge or increased secretions
  • Local irritation or pruritus
  • Vaginal discomfort

Common (dermatologic preparations):

  • Erythema and skin irritation
  • Burning or stinging sensation
  • Dryness and peeling
  • Photosensitivity (especially at higher concentrations)

Uncommon:

  • Contact dermatitis or allergic reactions
  • Hyperpigmentation (paradoxical, especially in darker skin types)
  • Superficial skin erosions (with high-concentration peels)

Rare:

  • Severe chemical burns (with improper use of high-concentration products)
  • Systemic lactic acidosis (only reported with massive dermal application to compromised skin barrier)

Most adverse effects are concentration-dependent and resolve with discontinuation or reduction in frequency of application. Initial use may cause mild irritation that often improves with continued use as the skin acclimates.

Contraindications and warnings

Absolute contraindications:

  • Known hypersensitivity to lactic acid or formulation components
  • Active vaginal infection requiring antimicrobial therapy (for vaginal preparations—use after or concurrently with appropriate treatment)

Relative contraindications and precautions:

  • Open wounds or severely compromised skin barrier (risk of excessive absorption)
  • Inflammatory skin conditions (eczema, psoriasis in active phase) in area of application
  • Recent chemical or laser procedures (wait for adequate healing)
  • Concurrent use of other potentially irritating topical agents

Pregnancy and lactation: Lactic acid vaginal preparations are generally considered safe during pregnancy (FDA has not assigned a formal pregnancy category to most topical preparations, but risk is considered minimal). Topical dermatologic use is also considered low risk. Lactating women may use lactic acid topically, but application to the breast area should be avoided or the area should be thoroughly cleansed before nursing.

Pediatric use: Safety and efficacy in prepubertal children have not been established for vaginal preparations. Dermatologic preparations may be used in children under medical supervision, typically at lower concentrations.

Sun exposure: Patients using lactic acid on the face or other sun-exposed areas should be counseled to use broad-spectrum sunscreen and limit sun exposure, as alpha-hydroxy acids may increase photosensitivity and risk of sunburn for up to a week after application.

Drug interactions

Lactic acid has minimal systemic drug interactions due to its topical administration and rapid metabolism. Interactions are primarily related to concurrent topical therapies.

Topical interactions:

  • Other alpha-hydroxy acids or beta-hydroxy acids (salicylic acid): Additive irritation; increased risk of excessive desquamation and chemical burns. If combination therapy is desired, products should be used at different times or on alternating days.
  • Retinoids (tretinoin, adapalene): Concurrent use may cause excessive irritation, erythema, and peeling. Many dermatologists recommend applying these agents on alternating evenings or using lactic acid in the morning and retinoids at night.
  • Benzoyl peroxide: May increase skin irritation when used concurrently. Alternating application times is advisable.
  • Physical exfoliants or abrasive cleansers: Additive mechanical and chemical irritation; avoid concurrent use.

Systemic interactions:

No clinically significant systemic drug interactions have been documented with topical lactic acid preparations. Even with systemic absorption, the amount is insufficient to affect hepatic metabolism or renal excretion of other drugs.

pH-dependent interactions (vaginal use):

Lactic acid may theoretically reduce the efficacy of pH-sensitive vaginal medications if used simultaneously, though this is rarely clinically significant. Patients should be advised to separate administration by several hours when using multiple vaginal products.

Clinical pearls

  • Bacterial vaginosis maintenance: Lactic acid vaginal gel reduces BV recurrence by approximately 50% when used regularly after completing antibiotic therapy. This makes it a valuable adjunct in women with frequent recurrences.
  • pH specificity: Normal vaginal pH is 3.8-4.5. In bacterial vaginosis, pH rises above 4.5. Lactic acid preparations are formulated to restore this acidic environment, which is the key to their therapeutic effect.
  • Not an antibiotic alternative: While lactic acid may help with mild cases or prevention, acute bacterial vaginosis typically requires antibiotic treatment (metronidazole or clindamycin). Lactic acid is best used as adjunctive or maintenance therapy.
  • Chemical peel considerations: The depth of penetration and degree of exfoliation increase with higher concentrations, lower pH, longer contact time, and repeated applications. Medical supervision is essential for higher-concentration professional products.
  • Darker skin types: Patients with Fitzpatrick skin types IV-VI are at higher risk for post-inflammatory hyperpigmentation when using chemical exfoliants. Conservative concentrations and sun protection are especially important.
  • Acclimation period: When initiating dermatologic use, start with lower concentrations and less frequent application, gradually increasing as tolerance develops. This minimizes irritation.
  • Product formulation matters: The efficacy and irritation potential of lactic acid products depend not only on concentration but also on pH, vehicle, and presence of buffering or soothing agents. Free acid concentration (determined by pH) is more important than total lactic acid concentration.
  • Lactobacilli and lactic acid: While lactic acid creates an environment favorable for lactobacilli, it does not directly replenish these organisms. Some clinicians combine lactic acid therapy with probiotic lactobacilli supplements (oral or vaginal) for bacterial vaginosis prevention, though evidence for added benefit is mixed.

Practice questions

1. A 28-year-old woman presents with recurrent bacterial vaginosis, having had three episodes in the past year despite completing appropriate antibiotic courses. Vaginal pH is 5.2, and whiff test is positive. After treating the current episode with metronidazole, which mechanism best explains how maintenance lactic acid therapy would reduce future recurrences?

Answer: C. Lactic acid works by lowering vaginal pH to 3.8-4.5, creating an acidic environment that inhibits pathogenic bacteria while supporting colonization by beneficial lactobacilli. This pH restoration is the primary mechanism for preventing BV recurrence. Lactic acid is not a bactericidal antibiotic and does not work through direct antimicrobial mechanisms like protein synthesis inhibition or cell wall disruption, nor does it enhance systemic immunity.

2. A 45-year-old woman with mild photoaging begins using a lactic acid cream for facial exfoliation. After 2 weeks, she develops erythema and mild burning. She is also using tretinoin cream nightly, vitamin C serum in the morning, and benzoyl peroxide spot treatment. Which recommendation would best minimize her irritation while maintaining therapeutic benefit?

Answer: C. The patient is experiencing additive irritation from using multiple potentially irritating agents (lactic acid, tretinoin, vitamin C, benzoyl peroxide) concurrently. Separating lactic acid and tretinoin application times and reducing frequency (alternate evenings for tretinoin) allows the skin barrier to recover while maintaining benefits. Increasing concentration or frequency would worsen irritation, while discontinuing all products is unnecessarily conservative. Topical corticosteroids are not appropriate for routine cosmetic irritation.

3. A 32-year-old woman in her first trimester of pregnancy is diagnosed with bacterial vaginosis. After discussing treatment options, she asks about using lactic acid vaginal gel instead of oral antibiotics because she is concerned about medication safety during pregnancy. What is the most appropriate counseling regarding lactic acid for her acute infection?

Answer: B. While lactic acid is safe during pregnancy, it is not sufficient as sole therapy for acute bacterial vaginosis. Acute BV requires antibiotic treatment (metronidazole or clindamycin, both safe in pregnancy) to resolve the infection. Lactic acid is best used as adjunctive therapy during treatment or as maintenance therapy after antibiotic cure to prevent recurrence. It is not contraindicated in pregnancy and does not require trimester restrictions or dose adjustments for topical vaginal use.

Frequently asked questions

How does lactic acid work for bacterial vaginosis?

Lactic acid works by lowering vaginal pH to the normal acidic range of 3.8-4.5. This acidic environment inhibits the growth of pathogenic bacteria like Gardnerella vaginalis and anaerobes that cause bacterial vaginosis, while simultaneously creating favorable conditions for beneficial lactobacilli to recolonize the vagina. The restored acidic pH disrupts bacterial biofilms and prevents pathogen adherence to vaginal epithelium, helping to maintain a healthy vaginal microbiome.

What are the side effects of lactic acid?

The most common side effects of lactic acid are local reactions at the application site. For vaginal preparations, these include burning, stinging, increased discharge, and mild discomfort, which are usually temporary. For skin applications, expect redness, irritation, dryness, peeling, and increased sun sensitivity. These effects are typically concentration-dependent and mild. Serious side effects like chemical burns or allergic reactions are rare and usually occur only with improper use of high-concentration products or in hypersensitive individuals.

Is lactic acid safe during pregnancy?

Yes, lactic acid is generally considered safe during pregnancy. Vaginal lactic acid preparations are commonly used in pregnant women for treating bacterial vaginosis and maintaining vaginal pH, with minimal systemic absorption and no known fetal risks. Topical dermatologic use is also considered low risk. Because lactic acid is a natural component of the body's metabolism and is applied topically with minimal absorption, it does not pose the same concerns as systemic medications during pregnancy.

Can I use lactic acid with retinol?

You can use lactic acid and retinol together, but they should typically be applied at different times to minimize irritation. Many dermatologists recommend using lactic acid in the morning and retinol at night, or alternating them on different evenings. Using both simultaneously can cause excessive irritation, redness, peeling, and compromise your skin barrier. Start slowly with each product individually, allow your skin to acclimate, and only combine them under guidance from a dermatologist if needed for your specific skin concerns.

How often should I use lactic acid for BV prevention?

For bacterial vaginosis prevention and maintenance therapy, lactic acid vaginal gel is typically used regularly after completing antibiotic treatment. Clinical studies show that consistent application reduces BV recurrence by approximately 50%. The exact frequency should follow product labeling and your healthcare provider's recommendations based on your individual risk factors and history of recurrence. Regular maintenance dosing helps sustain normal vaginal pH and flora over the long term.

Conditions it is used for

bacterial vaginosisatrophic vaginitisichthyosis vulgarisxerosisacne vulgarismelasmakeratosis pilarisphotoaging
metronidazoleclindamycinglycolic acidsalicylic acidtretinoinazelaic acidbenzoyl peroxidehydroquinone

Sources and further reading

DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: G01AD01

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.